3086417-33-3
3086417-33-3
Chemical Structure
GLP-1R agonist 27
- CAS No.: 3086417-33-3
- Formula:C32H33N5O4Se
- Molecular Weight:630.60
InChIKey: QBOBOECCQDQBKM-VWLOTQADSA-N
SMILES: OC(C1=CC(N2C[C@@H]3CCO3)=C(N=C2CN4CCC(C5=NC([Se]CC6=C(C=C(C=C6)C#N)OC)=CC=C5)CC4)C=C1)=O
Biological Activity: GLP-1R agonist 27 (compound 21) is a potent and orally active GLP-1R agonist. GLP-1R agonist 27 promots cyclic adenosine monophosphate (cAMP) accumulation. GLP-1R agonist 27 reduces blood glucose levels and food intake. GLP-1R agonist 27 has the potential for the research of obesity and type 2 diabetes mellitus (T2DM)[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
GLP-1R agonist 27 | GLP-1R agonist 27 (compound 21) is a potent and orally active GLP-1R agonist. GLP-1R agonist 27 promots cyclic adenosine monophosphate (cAMP) accumulation. GLP-1R agonist 27 reduces blood glucose levels and food intake. GLP-1R agonist 27 has the potential for the research of obesity and type 2 diabetes mellitus (T2DM). | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
